Digital Pathway - Navigating the Diagnosis and Management of Heart Failure in Women: Identifying and Understanding the Gaps to Improve Outcomes
The prevalence of heart failure (HF) is greater in women compared to men; however, significant gaps exist in the management of women with heart failure.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CDE
- 1.00 Participation
Digital Pathway - The Disproportionate Burden of Atrial Fibrillation in High-Risk African American Patients with Cardiometabolic Comorbidities
Atrial fibrillation (AF) remains underdiagnosed, particularly in African American patients with a high burden of AF risk factors, such as those with cardiometabolic comorbidities.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 1.00 ABIM MOC and AMA PRA Category 1 Credit™
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CDE
- 1.00 Participation
Digital Pathway - The Intersection of NASH and Cardiometabolic Diseases: Implications for Screening, Diagnosis, and Management
Non-alcoholic steatohepatitis (NASH) is a metabolic-based constellation of multiple organ pathology that overlaps with obesity, prediabetes, type 2 diabetes, and cardiovascular disease.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 2.00 ABIM MOC and AMA PRA Category 1 Credit™
- 2.00 ACPE Pharmacy
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 CDE
- 2.00 Participation
Escape Room Experience: Challenges and Advances in the Management of Anemia of CKD
Anemia is a common comorbidity in patients with chronic kidney disease (CKD), and is associated with significant morbidity and impacts on quality of life.
Category
- CMHC
Format
- Video
Credits
- 1.25 ABIM MOC and AMA PRA Category 1 Credit™
- 1.25 ACPE Pharmacy
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
- 1.25 CDE
- 1.25 Participation
Escape Room Experience: LDL-Lowering Therapy and Beyond - Applying Advances to Patient Care
Lowering LDL-C effectively and safely is crucial to prevent and lower the risk of adverse cardiovascular events, however, LDL-C goal achievement remains suboptimal, including in high-risk and very high-risk patients.
Category
- CMHC
Format
- Video
Credits
- 1.25 ABIM MOC and AMA PRA Category 1 Credit™
- 1.25 ACPE Pharmacy
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
- 1.25 CDE
- 1.25 Participation